Dhampur Bio Organics Limited — Board Meeting, 02-05-2025: Outcome of Board Meeting

Dhampur Bio Organics has announced a board meeting on May 2, 2025, approving consolidated financial results for the quarter and year ended March 31, 2025. The company reported a net profit of ₹14.69 Cr on revenue of ₹2,692.98 Cr for the year. A final dividend of ₹1.25/share, totaling ₹8.30 Cr, has been proposed. The board re-appointed Vijay Kumar Goel as Chairman & Executive Director and Gautam Goel as MD & CEO for three years, plus Sandeep Kumar as Whole-time Director for one year, all pending shareholder approval. GSK and Associates will serve as Secretarial Auditors for five years.